Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years.
Moriwaki T, Nishina T, Sakai Y, Yamamoto Y, Shimada M, Ishida H, Amagai K, Sato M, Endo S, Negoro Y, Kuramochi H, Denda T, Hatachi Y, Ikezawa K, Nakajima G, Bando Y, Tsuji A, Yamamoto Y, Morimoto M, Kobayashi K, Hyodo I.
Moriwaki T, et al. Among authors: nakajima g.
Jpn J Clin Oncol. 2022 Jul 8;52(7):725-734. doi: 10.1093/jjco/hyac073.
Jpn J Clin Oncol. 2022.
PMID: 35470391
Clinical Trial.